Skip to main content
EIKNSector not reported

Eikon Therapeutics, Inc. (EIKN) Insider Trading

In the last 90 days, 8 Eikon Therapeutics, Inc. (EIKN) insiders reported 8 open-market purchases totaling $8,248,360 and no sales. The most recent open-market purchase was reported on Sep 3, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$8,248,360
Corporate buyers
8
Latest transaction
Sep 3, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 3, 2026Peter Svennilson10% OwnerOpen Market Purchase89,200$11.56$1,031,045
Sep 3, 2026Tim Kutzkey10% OwnerOpen Market Purchase89,200$11.56$1,031,045
Sep 3, 2026Column Group IV-A LP10% OwnerOpen Market Purchase89,200$11.56$1,031,045
Sep 3, 2026Column Group IV LP10% OwnerOpen Market Purchase89,200$11.56$1,031,045
Sep 3, 2026Column Group IV GP LP10% OwnerOpen Market Purchase89,200$11.56$1,031,045
Sep 3, 2026Column Group Opportunity III LP10% OwnerOpen Market Purchase89,200$11.56$1,031,045
Sep 3, 2026TCG Opportunity III GP LLC10% OwnerOpen Market Purchase89,200$11.56$1,031,045
Sep 3, 2026Column Group Opportunity III GP LP10% OwnerOpen Market Purchase89,200$11.56$1,031,045

Common questions

EIKN insider trading FAQ

Are EIKN insiders buying or selling?
Over the last 90 days, EIKN insiders were net buyers, reporting $8,248,360 of open-market purchases and $0.00 of sales.
When was the last EIKN insider purchase?
The most recent open-market purchase of Eikon Therapeutics, Inc. stock by an insider was reported on Sep 3, 2026, one of 8 purchases in the last 90 days.
Where does EIKN insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Eikon Therapeutics, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.